February 9, 2017, 3:00pm EST                                                                                  Invest Alongside Billionaires For $297/Qtr


Stocks are hitting new record highs today.  That includes the Dow, the S&P 500 and the Nasdaq.

We’ve now seen about 60% of the earnings for Q4, and earnings are very good. As we’ve discussed, earnings guidance and consensus views are made to be beaten.  Factset says that, on average, about 67% of S&P 500 companies beat the consensus view on earnings.  For Q4, that number, as of last Friday, was 65%.

More importantly, the earnings growth rate for Q4 is +4.6% thus far.  That’s better than the 3.1% that was predicted, coming into the earnings season.  And that’s the first two consecutive quarters of year-over-year positive EPS growth in a couple of years.

So we have positive earnings surprises driving stocks higher.  And finally, revenue growth is coming.  After six consecutive quarters of revenue contraction, earnings for U.S. companies had a second consecutive quarter of growth.  And the quarters ahead should be much better.

Clearly, in the weak growth environment, the focus has clearly been cutting costs, refinancing debt, selling non-core assets, and buying back shares.  That’s all a recipe for juicing EPS, even though revenue growth is sluggish, if existent.

So for all of the people that are constantly hand wringing about the levels of the stock market, ask them this:  What happens when you take these companies that are growing earnings by optimizing margins in a 1% growth world, and you give them 3%-4% economic growth? Earnings go up. What happens when you take a profitable company and cut the tax burden by 15 to 20 percentage points?  Earnings go up.

When earnings go up, price to earnings goes down.  And valuations can become very, very cheap.

We have companies that have been forced to streamline to survive. And now we’re in the early days of a regime shift, where tax cuts will work for them, deregulation will work for them, and a big infrastructure spend will pop demand, to actually fuel some revenue growth.

Below is a nice chart from Yardeni.  You can see the flattish revenue growth, but earnings divergence over the past five years.

rev and earnings

On the right hand axis, next year’s earnings on the S&P 500 are expected around $133.  That doesn’t take into account the impact of a corporate tax cut, which Standard & Poors research has suggested could bump that number up to the mid $150s ($1.31 added for every 1% cut in the corporate tax rate). That would dramatically widen the revenue, earnings divergence — or make the closing of this gap that much more aggressive.

For help building a high potential portfolio for 2017, follow me in our Billionaire’s Portfolio, where you look over my shoulder as I follow the world’s best investors into their best stocks.  Our portfolio more than doubled the return of the S&P 500 in 2016.  You can join me here and get positioned for a big 2017.

Last week the Wall Street Journal published a report on 70 activist campaigns, looking back over the past six years. No surprise, in evaluating these campaigns, they found that activism works.

With the ability to buy controlling stakes in public companies, we know that activist investors can influence outcomes in the stocks they buy. They have the unique privilege of controlling their own destiny. With that edge, these investors have proven to produce a significant return over what the broader market gives you over time, on average.

When we follow these activist investors into stocks, piggybacking their moves, not only do we get to participate in their performance, for free, but we get an investor on our side that has a lot of money on the line (both their investor’s money and often a lot of their personal money). With that, we get to follow the lead of someone with power and influence, and with every incentive to see the campaign succeed.

Given their record of success, when an activist investor takes a position in a stock and publicly gives a price target for the stock, we take note.

In each of the five stocks listed below, a billionaire investor or hedge fund is calling for a double:

1) Macy’s (NYSE:M) – Starboard Value, a top $4 billion activist hedge fund, said at the Ira Sohn Hedge Fund Conference that Macy’s could be worth $125 a share if the company would sell or spin off its real estate. The stock today sells for $50.36. If Starboard is right, the stock has a 172% potential return.

2) NCR (NYSE:NCR) – Marcato Capital, a $3 billion activist hedge fund run by Bill Ackman’s protégé, Mick McGuire, said that NCR could be worth as much as $51 to $59 a share. The stock is $25 today. If McGuire is right, NCR has a double in it (or more).

3) Bob Evans (NASDAQ:BOBE) – Sandell Asset Management, a top billion dollar plus activist hedge fund, said that Bob Evans could be worth as much as $90 a share if it sold or spun off its real estate. Bob Evans sells for $44 a share. A move to $90 would be a 105% return.

4) Yum Brands (NYSE:YUM) – Carl Icahn protégé, Keith Meister, who runs the $8 billion activist hedge fund Corvex Management, said at Ira Sohn this year that YUM could be worth as much as $130 a share, if the company spun off its Chinese operations. With the stock selling at $70 that is an 86% potential return.

5) Brookdale Senior Living (NYSE:BKD) – Billionaire Larry Robbins of the $15 billion hedge fund Glenview Capital Management has said that Brookdale could double, as the company’s real estate was worth as much as its share price. That is when the stock was trading at $30. Today Brookdale sells for $22.87 which would imply a 161% potential return.

Sign up for our Free ebook, The Little Black Book of Billionaire Secrets, and learn how to follow the “best ideas” of the world’s top billionaire investors. You don’t have to be rich to take part. You don’t have to pay the hefty 2% management fee and 20% profit share to a hedge fund. You can follow the lead of powerful billionaire investors by simply buying the same stocks they do, in your own brokerage account.

How BillionairesPortfolio.com Predicted the Big Pop In Sarepta Therapeutics

The Carl Icahn Effect & How It Can Work For You

Related: stock market, stocks, finance, investing, billionaire, hedge funds, billionaires, dow jones, wall street